WuXi AppTec Co., Ltd. Share Price and Company Fundamentals
Last traded: Today at 8:08 AM
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Key Metrics
PE ratio
20.59
PB ratio
4.35
Dividend yield
0.87%
Beta
0.62
Market cap
$368.24B
Enterprise value
$324.57B
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Full time employees | 39414 |
| Website | https://www.wuxiapptec.com |
| Mailing address | 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 China |
| Phone / Fax | 86 21 5046 1111 / 86 21 5046 1000 |
Dividends
Dividend yield
0.87%
Dividend amount
$1.06
Payout ratio
18.57%
5Y Avg. yield
-%
WuXi AppTec Co., Ltd. paid $1.06 dividend and the ex-dividend date was 08 Sep 2025.The dividend payout ratio is 18.57%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.2359 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on WuXi AppTec Co., Ltd..
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Ge Li Ph.D. | Co-Founder, Executive Chairman, President & CEO | 58 | |
| Dr. Minzhang Chen Ph.D. | Co-CEO & Executive Director | 56 | |
| Dr. Qing Yang Ph.D. | Co-CEO & Executive Director | 56 | |
| Ms. Ming Shi | Senior VP & CFO | 51 | |
| Mr. Zhaohui Zhang | COO of China, Executive VP & Executive Director | 56 | |
| Mr. Ruijia Tang | IR Director | ||
| Dr. Howard Wu J.D. | Senior Vice President of Legal Department & Human Resources Department | ||
| Mr. Tao Guo Ph.D. | Senior Vice President of RCS IPM | ||
| Dr. Youchu Wang Ph.D. | Senior Vice President of API Early Phase Development | ||
| Mr. Feng Zhang | Senior Vice President of API Manufacturing | 48 |
Profitability and management effectiveness
Profit margin
34.17%
Operating margin
38.14%
Return on assets
11.28%
Return on equity
25.91%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of WuXi AppTec Co., Ltd. is 368.24B and its enterprise value is 324.57B. The enterprise value to revenue ratio of 2359 is 7.40. The enterprise value to EBITDA ratio of 2359 is 18.03.
The 2359's stocks Beta value is 0.62 making it 38% less volatile compared to HKEX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
WuXi AppTec Co., Ltd. (HKEX:2359) Frequently Asked Questions
1. What is WuXi AppTec Co., Ltd.'s Stock Symbol?
WuXi AppTec Co., Ltd. trades on HKEX under the ticker symbol "2359".
2. What is WuXi AppTec Co., Ltd.'s stock price today?
One share of 2359 stock can currently be purchased for approximately $121.7.
3. How can I contact WuXi AppTec Co., Ltd.?
WuXi AppTec Co., Ltd.'s mailing address is 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 China. The company can be reached via phone at 86 21 5046 1111.
4. What is WuXi AppTec Co., Ltd.'s official website?
The official website of WuXi AppTec Co., Ltd. is https://www.wuxiapptec.com.